C. Rothrock

发表

Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.

M. Koch, M. Iruela-Arispe, Yoon-Jin Lee, 2010, Cancer research.

Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment.

Yoon-Jin Lee, S. Ryeom, Sam S. Yoon, 2010, Cancer research.

Cancer esearch oenvironment and Immunology erential Effects of VEGFR-1 and VEGFR-2 Inhibition on R or Metastases Based on Host Organ Environment

S. Ryeom, Sam S. Yoon, Jin Lee, 2010 .

Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment.

Yoon-Jin Lee, S. Ryeom, Sam S. Yoon, 2010, Cancer research.

Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.

P. Park, D. Sahani, R. Jain, 2011, International journal of radiation oncology, biology, physics.

Cancer esearch oenvironment and Immunology erential Effects of VEGFR-1 and VEGFR-2 Inhibition on R or Metastases Based on Host Organ Environment

S. Ryeom, Sam S. Yoon, Jin Lee, 2010 .

Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma.

P. Park, T. Jacks, R. Weissleder, 2009, International Journal of Radiation Oncology, Biology, Physics.

Tumor Escape from Endogenous, Extracellular Matrix–Associated Angiogenesis Inhibitors by Up-Regulation of Multiple Proangiogenic Factors

M. Koch, S. Ryeom, Sam S. Yoon, 2008, Clinical Cancer Research.

Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma.

T. Jacks, R. Weissleder, U. Mahmood, 2009, International Journal of Radiation Oncology, Biology, Physics.

Phase II Study of Neoadjuvant Bevacizumab and Radiation Therapy for Resectable Soft Tissue Sarcomas

D. Sahani, R. Jain, A. Kambadakone, 2011 .